high
morbid
associ
sar
highlight
observ
even
total
lung
fi
eld
involv
consolid
chest
radiograph
patient
requir
supplement
oxygen
maintain
satisfactori
oxygen
peiri
et
al
show
peak
nasopharyng
viral
load
day
ill
follow
progress
decreas
rate
viral
shed
nasopharynx
stool
urin
day
day
symptom
onset
patient
serial
measur
revers
transcriptionpolymeras
chain
reaction
thu
clinic
worsen
patient
sar
phase
second
week
ill
like
result
immunemedi
lung
injuri
due
overexuber
host
respons
rather
uncontrol
viral
replic
sar
spread
mainli
close
persontoperson
contact
via
droplet
transmiss
fomit
global
outbreak
sar
patient
progress
acut
respiratori
distress
syndrom
ard
necessit
invas
ventilatori
support
reach
high
viral
load
nasopharynx
peak
day
ill
thu
hcw
particularli
prone
infect
care
patient
close
distanc
data
emphas
need
adequ
respiratori
protect
addit
strict
contact
droplet
precaut
manag
patient
pneumonia
due
highli
infecti
diseas
sever
uncontrol
studi
shown
singlecircuit
noninvas
ventil
niv
lifesav
patient
respiratori
failur
due
sar
infect
among
patient
meet
clinic
criteria
sar
hospit
infecti
diseas
beij
develop
acut
respiratori
failur
arf
day
onset
sar
among
patient
exhibit
hypercapnia
paco
mmhg
hypercapn
event
occur
within
week
admiss
niv
institut
patient
patient
intoler
remain
patient
sar
niv
initi
day
arf
onset
hour
niv
therapi
led
signifi
cant
improv
pao
fio
reduc
respiratori
rate
p
endotrach
intub
requir
onethird
patient
despit
favor
respons
niv
initi
remark
pulmonari
barotrauma
note
patient
niv
overal
fatal
rate
week
higher
among
need
niv
none
hcw
contract
sar
author
conclud
niv
feasibl
appropri
treatment
arf
due
sar
infect
anoth
studi
niv
appli
via
oronas
mask
sar
patient
without
chronic
obstruct
pulmonari
diseas
copd
develop
sever
hypoxem
respiratori
failur
hospit
hong
kong
effi
cient
room
air
exchang
time
instal
power
exhaust
fan
provid
air
chang
per
hour
stringent
infect
control
measur
full
person
protect
equip
ppe
addit
viralbacteri
fi
lter
exhal
port
niv
devic
mean
age
patient
year
mean
acut
physiolog
chronic
health
evalu
apach
ii
score
sar
cov
serolog
posit
patient
niv
start
mean
day
symptom
onset
mean
durat
niv
usag
h
endotrach
intub
avoid
patient
icu
stay
shorter
requir
intub
vs
day
p
chest
radiographi
score
within
h
niv
lower
vs
p
compar
intub
patient
intub
avoid
predict
mark
reduct
respiratori
rate
breath
per
min
supplement
oxygen
requir
lmin
within
h
niv
clinic
infect
among
hcw
care
patient
receiv
niv
hcw
consent
blood
serolog
test
neg
sar
cov
niv
appear
effect
treatment
arf
patient
sar
use
safe
hcw
singlecent
studi
retrospect
analysi
conduct
patient
respiratori
failur
identifi
ed
hong
kong
hospit
author
sar
databas
intub
rate
mortal
secondari
outcom
hospit
util
niv
standard
infect
control
condit
niv
hospit
describ
compar
hospit
use
invas
mechan
ventil
imv
hospit
two
hospit
group
compar
demograph
clinic
profi
le
patient
niv
hospit
n
higher
lactat
dehydrogenas
level
wors
radiograph
score
admiss
compar
imv
hospit
n
niv
hospit
lower
adjust
odd
ratio
intub
confi
denc
interv
ci
p
death
ci
p
clinic
transmiss
sar
among
hcw
caus
use
niv
compar
imv
niv
initi
ventilatori
support
arf
presenc
sar
appear
safe
also
associ
reduc
need
imv
low
mortal
studi
retrospect
studi
xiao
et
al
describ
niv
exposur
risk
factor
associ
clinic
sar
infect
two
hcw
guangzhou
china
risk
factor
includ
involv
patient
resuscit
imv
rel
risk
develop
sar
hcw
toronto
involv
intub
sar
patient
versu
contrast
niv
associ
statist
signifi
cant
risk
hcw
expos
hcw
vs
nonexpos
risk
ratio
p
probabl
tracheal
suction
gener
perform
patient
ventil
niv
studi
sampl
size
small
subsequ
retrospect
multicent
cohort
studi
hcw
involv
manag
sar
patient
toronto
presenc
room
fi
beropt
intub
p
electrocardiographi
p
unprotect
eye
contact
secret
p
patient
apach
ii
score
p
patient
pao
fio
p
associ
increas
risk
transmiss
sar
cov
larg
casecontrol
studi
involv
medic
ward
hospit
guangzhou
hong
kong
niv
identifi
ed
independ
risk
factor
superspread
nosocomi
outbreak
sar
ci
p
systemat
review
fi
casecontrol
fi
retrospect
cohort
studi
relat
sar
identifi
ed
four
procedur
associ
increas
risk
transmiss
sar
hcw
addit
infl
uenza
outbreak
investig
conduct
comput
fl
uid
dynam
analysi
describ
applic
niv
patient
hospit
hypercapn
respiratori
failur
due
acut
exacerb
copd
infl
uenza
viru
patient
gener
medic
ward
imbalanc
airfl
ow
relat
differ
higheffi
cienci
particul
air
hepa
fi
lter
set
ward
appear
convert
droplet
subject
airborn
transmiss
result
nosocomi
infect
due
infl
uenza
viru
seen
fi
rst
patient
affect
sever
patient
adjac
bay
ward
noninvas
ventil
commenc
strict
infect
control
measur
recommend
tabl
patient
sar
emerg
respiratori
infect
start
patient
nasal
oxygen
lmin
fail
maintain
target
spo
inspiratori
posit
airway
pressur
ipap
adjust
achiev
respiratori
rate
breath
per
minut
exhal
tidal
volum
mlkg
expiratori
posit
airway
pressur
epap
adjust
achiev
target
oxygen
minimum
carbon
dioxid
rebreath
criteria
switch
intub
includ
intoler
niv
patient
fatigu
supplement
oxygen
lmin
fail
maintain
least
spo
niv
hcw
take
precaut
manag
patient
communityacquir
pneumonia
cap
unknown
etiolog
complic
respiratori
failur
experiment
studi
base
sophist
human
patient
simul
laser
visual
techniqu
shown
maximum
exhal
air
particl
dispers
distanc
patient
receiv
niv
via
resm
ultra
mirag
mask
along
exhal
port
research
group
demonstr
maximum
exhal
air
dispers
distanc
respiron
comfortful
mask
predict
direct
exhal
diffus
perpendicular
patient
leakag
though
respiron
imag
mask
connect
whisper
swivel
exhal
port
much
extens
diffus
even
low
ipap
cmh
whisper
swivel
effi
cient
exhal
devic
prevent
carbon
dioxid
rebreath
advis
use
exhal
port
manag
patient
highli
infecti
condit
sar
fear
caus
major
nosocomi
infect
also
import
avoid
use
high
ipap
could
lead
wider
distribut
staff
educ
limit
opportun
exposur
limit
aerosol
gener
procedur
limit
number
hcw
present
b
effect
use
time
patient
contact
c
gown
gown
without
contamin
exhal
air
substanti
room
contamin
data
import
clinic
implic
regard
prevent
futur
nosocomi
outbreak
sar
highli
infecti
condit
pandem
infl
uenza
noninvas
ventil
appli
patient
sever
cap
adequ
protect
hcw
potenti
risk
transmiss
organ
spread
via
either
deliber
accident
mask
interfac
leakag
fl
ow
compens
caus
dispers
contamin
aerosol
patient
respiratori
failur
undergo
niv
via
nasal
mask
air
leakag
may
occur
mouth
rout
exhal
valv
exampl
patient
may
loosen
mask
strap
reliev
discomfort
around
nasal
bridg
air
leakag
nasal
bridg
defi
nite
potenti
sourc
transmiss
viral
infect
care
mask
fi
tting
import
success
safe
applic
niv
addit
viralbacteri
fi
lter
breath
system
niv
mask
exhal
port
use
dualcircuit
niv
may
reduc
risk
nosocomi
transmiss
viral
infect
view
observ
higher
ventil
pressur
result
wider
dispers
exhal
air
higher
concentr
air
leakag
advis
start
niv
low
ipap
level
cmh
gradual
increas
necessari
inde
sarsrel
arf
report
respond
readili
low
posit
pressur
cpap
cmh
ipap
cmh
epap
cmh
higher
pressur
avoid
common
fi
nding
spontan
pneumomediastinum
pneumothorax
sar
pandem
infl
uenza
infect
recommend
niv
appli
suitabl
patient
eg
mild
moder
acut
hypercapn
respiratori
failur
acut
pulmonari
edema
resolv
ard
via
helmet
mask
doublecircuit
tube
total
fullfac
mask
fi
lter
avoid
heat
humidifi
cation
addit
prudent
isol
patient
coupl
protect
measur
hcw
patient
tabl
health
protect
agenc
uk
recommend
airborn
precaut
appli
niv
patient
infect
also
recent
world
health
organ
interim
guidanc
manag
novel
cov
also
recommend
use
niv
mild
case
ard
without
hemodynam
instabl
interim
guidelin
prevent
control
acut
respiratori
diseas
health
care
includ
niv
among
aerosolgener
procedur
possibl
increas
risk
respiratori
pathogen
transmiss
addit
maintain
contact
droplet
standard
precaut
among
hcw
provid
routin
care
patient
recommend
full
ppe
hcw
cover
torso
arm
eye
nose
mouth
includ
longsleev
gown
singleus
glove
eye
protect
mask
equival
minimum
level
respiratori
protect
niv
provid
adequ
ventil
singl
room
also
expiratori
port
bacterialvir
fi
lter
reduc
aerosol
emiss
emerg
infecti
diseas
sar
highli
infecti
associ
signifi
cant
morbid
mortal
niv
may
play
limit
support
role
earli
ardsacut
lung
injuri
bridg
invas
mechan
ventil
sar
emerg
respiratori
infect
contraind
howev
critic
ill
patient
multiorgan
failur
hemodynam
instabl
applic
niv
may
potenti
dispers
infect
aerosol
research
need
examin
safeti
exhal
air
dispers
distanc
applic
niv
via
mask
includ
helmet
use
doublecircuit
tube
better
understand
area
hcw
better
protect
within
danger
distanc
manag
patient
arf
due
highli
infecti
diseas
research
also
need
regard
technic
improv
niv
mask
viralbacteri
fi
lter
well
design
safer
hospit
ward
environ
prevent
nosocomi
transmiss
infect
advanc
knowledg
research
area
facilit
manag
arf
due
futur
sar
outbreak
emerg
infecti
diseas
pandem
infl
uenza
niv
may
play
support
role
earli
ardsacut
lung
injuri
bridg
invas
mechan
ventil
patient
sar
emerg
infect
although
contraind
critic
ill
patient
multiorgan
failur
hemodynam
instabl
addit
strict
contact
droplet
precaut
hcw
adequ
respiratori
protect
manag
patient
sar
applic
niv
may
dispers
potenti
infect
aerosol
research
need
determin
exhal
air
dispers
distanc
safeti
applic
niv
via
mask
eg
helmet
mask
total
fullfac
mask
use
dual
circuit
health
care
provid
better
protect
within
danger
area
manag
patient
arf
due
highli
infecti
diseas
research
need
regard
technic
improv
noninvas
positivepressur
ventil
mask
viralbacteri
fi
lter
design
safer
hospit
ward
environ
adequ
air
chang
prevent
nosocomi
transmiss
infect
